16-66963283-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_024922.6(CES3):ā€‹c.187A>Gā€‹(p.Ile63Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

CES3
NM_024922.6 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0370
Variant links:
Genes affected
CES3 (HGNC:1865): (carboxylesterase 3) This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene is expressed in several tissues, particularly in colon, trachea and in brain, and the protein participates in colon and neural drug metabolism. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported, but the biological validity and/or full-length nature of some variants have not been determined.[provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3344838).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CES3NM_024922.6 linkuse as main transcriptc.187A>G p.Ile63Val missense_variant 2/13 ENST00000303334.9 NP_079198.2 Q6UWW8-1
CES3NM_001185177.2 linkuse as main transcriptc.187A>G p.Ile63Val missense_variant 2/13 NP_001172106.1 Q6UWW8A0A0C4DFY7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CES3ENST00000303334.9 linkuse as main transcriptc.187A>G p.Ile63Val missense_variant 2/131 NM_024922.6 ENSP00000304782.4 Q6UWW8-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461440
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727054
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 24, 2023The c.187A>G (p.I63V) alteration is located in exon 2 (coding exon 2) of the CES3 gene. This alteration results from a A to G substitution at nucleotide position 187, causing the isoleucine (I) at amino acid position 63 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
T;.
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.76
T;T
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.33
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.62
N;.
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-0.78
N;N
REVEL
Benign
0.16
Sift
Benign
0.18
T;T
Sift4G
Benign
0.28
T;T
Polyphen
0.99
D;.
Vest4
0.19
MutPred
0.76
Gain of catalytic residue at I63 (P = 0.0087);Gain of catalytic residue at I63 (P = 0.0087);
MVP
0.26
MPC
0.42
ClinPred
0.22
T
GERP RS
2.0
Varity_R
0.039
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr16-66997186; API